# Soundhound Ai, Inc.: financial statements, quarterly

SOUN · Nasdaq · CIK 1840856 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/soun.md) · [Financials](/companies/soun/financials.md) · [Filings](/companies/soun/filings.md) · [Insiders](/companies/soun/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/soun/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.3](/filings/0001840856-24-000040.md) | [17.1 d](/filings/0001840856-26-000006.md) | [11.6](/filings/0001628280-25-024654.md) | [13.5](/filings/0001628280-25-039596.md) | [25.1](/filings/0001840856-25-000022.md) | [34.5 d](/filings/0001840856-26-000006.md) | [29.1](/filings/0001840856-26-000015.md) | [42.7](/filings/0001840856-26-000022.md) | [42.0](/filings/0001840856-25-000022.md) | [55.1 d](/filings/0001840856-26-000006.md) | [44.2](/filings/0001840856-26-000015.md) | [61.9](/filings/0001840856-26-000022.md) |
| Cost of revenue | $m | [3.6](/filings/0001840856-24-000040.md) | [3.9 d](/filings/0001840856-26-000006.md) | [4.7](/filings/0001628280-25-024654.md) | [5.0](/filings/0001628280-25-039596.md) | [12.9](/filings/0001840856-25-000022.md) | [20.8 d](/filings/0001840856-26-000006.md) | [18.5](/filings/0001840856-26-000015.md) | [26.0](/filings/0001840856-26-000022.md) | [24.1](/filings/0001840856-25-000022.md) | [28.7 d](/filings/0001840856-26-000006.md) | [30.5](/filings/0001840856-26-000015.md) | [34.0](/filings/0001840856-26-000022.md) |
| Research and development | $m | [12.8](/filings/0001840856-24-000040.md) | [12.7 d](/filings/0001840856-26-000006.md) | [14.9](/filings/0001628280-25-024654.md) | [15.7](/filings/0001628280-25-039596.md) | [19.5](/filings/0001840856-25-000022.md) | [20.4 d](/filings/0001840856-26-000006.md) | [24.8](/filings/0001840856-26-000015.md) | [25.8](/filings/0001840856-26-000022.md) | [22.8](/filings/0001840856-25-000022.md) | [24.8 d](/filings/0001840856-26-000006.md) | [26.2](/filings/0001840856-26-000015.md) | [27.1](/filings/0001840856-26-000022.md) |
| Operating income | $m | [(14.5)](/filings/0001840856-24-000040.md) | [(12.4) d](/filings/0001840856-26-000006.md) | [(28.5)](/filings/0001628280-25-024654.md) | [(22.0)](/filings/0001628280-25-039596.md) | [(33.8)](/filings/0001840856-25-000022.md) | [(257) d](/filings/0001840856-26-000006.md) | [128](/filings/0001840856-26-000015.md) | [(78.1)](/filings/0001840856-26-000022.md) | [(116)](/filings/0001840856-25-000022.md) | [42.6 d](/filings/0001840856-26-000006.md) | [(22.7)](/filings/0001840856-26-000015.md) | [(43.3)](/filings/0001840856-26-000022.md) |
| Interest expense | $m | [5.4](/filings/0001840856-23-000059.md) | [5.5 d](/filings/0001840856-24-000013.md) | [5.7](/filings/0001840856-24-000019.md) | [4.1](/filings/0001628280-25-039596.md) | [1.1](/filings/0001840856-25-000022.md) | [1.3 d](/filings/0001840856-26-000006.md) | [0.2](/filings/0001840856-26-000015.md) | [0.2](/filings/0001840856-26-000022.md) | [0.2](/filings/0001840856-25-000022.md) | [0.1 d](/filings/0001840856-26-000006.md) | [0.1](/filings/0001840856-26-000015.md) | [0.1](/filings/0001840856-26-000022.md) |
| Income tax | $m | [1.6](/filings/0001840856-24-000040.md) | [1.6 d](/filings/0001840856-26-000006.md) | [0.3](/filings/0001628280-25-024654.md) | [0.6](/filings/0001628280-25-039596.md) | [(10.5)](/filings/0001840856-25-000022.md) | [0.3 d](/filings/0001840856-26-000006.md) | [0.8](/filings/0001840856-26-000015.md) | [1.3](/filings/0001840856-26-000022.md) | [0.5](/filings/0001840856-25-000022.md) | [2.2 d](/filings/0001840856-26-000006.md) | [0.8](/filings/0001840856-26-000015.md) | [2.2](/filings/0001840856-26-000022.md) |
| Net income | $m | [(20.2)](/filings/0001840856-24-000040.md) | [(18.0) d](/filings/0001840856-26-000006.md) | [(33.0)](/filings/0001628280-25-024654.md) | [(37.3)](/filings/0001628280-25-039596.md) | [(21.8)](/filings/0001840856-25-000022.md) | [(259) d](/filings/0001840856-26-000006.md) | [130](/filings/0001840856-26-000015.md) | [(74.7)](/filings/0001840856-26-000022.md) | [(109)](/filings/0001840856-25-000022.md) | [40.1 d](/filings/0001840856-26-000006.md) | [(25.0)](/filings/0001840856-26-000015.md) | [(42.8)](/filings/0001840856-26-000022.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001840856-24-000040.md) | not reported | [(0.12)](/filings/0001628280-25-024654.md) | [(0.11)](/filings/0001628280-25-039596.md) | [(0.06)](/filings/0001840856-25-000022.md) | not reported | [0.31](/filings/0001840856-26-000015.md) | [(0.19)](/filings/0001840856-26-000022.md) | [(0.27)](/filings/0001840856-25-000022.md) | not reported | [(0.11)](/filings/0001840856-26-000015.md) | [(0.10)](/filings/0001840856-26-000022.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001840856-24-000040.md) | not reported | [(0.12)](/filings/0001628280-25-024654.md) | [(0.11)](/filings/0001628280-25-039596.md) | [(0.06)](/filings/0001840856-25-000022.md) | not reported | [0.33](/filings/0001840856-26-000015.md) | [(0.19)](/filings/0001840856-26-000022.md) | [(0.27)](/filings/0001840856-25-000022.md) | not reported | [(0.06)](/filings/0001840856-26-000015.md) | [(0.10)](/filings/0001840856-26-000022.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [96.1](/filings/0001840856-24-000040.md) | [95.3](/filings/0001840856-26-000006.md) | [212](/filings/0001628280-25-024654.md) | [200](/filings/0001628280-25-039596.md) | [136](/filings/0001840856-25-000022.md) | [198](/filings/0001840856-26-000006.md) | [246](/filings/0001840856-26-000015.md) | [230](/filings/0001840856-26-000022.md) | [269](/filings/0001840856-25-000022.md) | [248](/filings/0001840856-26-000022.md) | [216](/filings/0001840856-26-000015.md) | [203](/filings/0001840856-26-000022.md) |
| Current assets | $m | [109](/filings/0001840856-23-000059.md) | [114](/filings/0001628280-25-011821.md) | [234](/filings/0001840856-24-000019.md) | [224](/filings/0001840856-24-000028.md) | [181](/filings/0001840856-24-000040.md) | [256](/filings/0001840856-26-000006.md) | [295](/filings/0001628280-25-024654.md) | [282](/filings/0001628280-25-039596.md) | [335](/filings/0001840856-25-000022.md) | [329](/filings/0001840856-26-000022.md) | [289](/filings/0001840856-26-000015.md) | [277](/filings/0001840856-26-000022.md) |
| Total assets | $m | [144](/filings/0001840856-23-000059.md) | [151](/filings/0001628280-25-011821.md) | [287](/filings/0001840856-24-000019.md) | [267](/filings/0001840856-24-000028.md) | [500](/filings/0001840856-24-000040.md) | [554](/filings/0001840856-26-000006.md) | [588](/filings/0001628280-25-024654.md) | [579](/filings/0001628280-25-039596.md) | [702](/filings/0001840856-25-000022.md) | [688](/filings/0001840856-26-000022.md) | [645](/filings/0001840856-26-000015.md) | [668](/filings/0001840856-26-000022.md) |
| Current liabilities | $m | [21.4](/filings/0001840856-23-000059.md) | [24.2](/filings/0001628280-25-011821.md) | [26.5](/filings/0001840856-24-000019.md) | [25.5](/filings/0001840856-24-000028.md) | [70.2](/filings/0001840856-24-000040.md) | [67.7](/filings/0001840856-26-000006.md) | [60.0](/filings/0001628280-25-024654.md) | [58.3](/filings/0001628280-25-039596.md) | [65.1](/filings/0001840856-25-000022.md) | [71.7](/filings/0001840856-26-000022.md) | [73.3](/filings/0001840856-26-000015.md) | [70.9](/filings/0001840856-26-000022.md) |
| Total liabilities | $m | [118](/filings/0001840856-23-000059.md) | [123](/filings/0001628280-25-011821.md) | [132](/filings/0001840856-24-000019.md) | [42.7](/filings/0001840856-24-000028.md) | [204](/filings/0001840856-24-000040.md) | [371](/filings/0001840856-26-000006.md) | [191](/filings/0001628280-25-024654.md) | [220](/filings/0001628280-25-039596.md) | [303](/filings/0001840856-25-000022.md) | [224](/filings/0001840856-26-000022.md) | [184](/filings/0001840856-26-000015.md) | [177](/filings/0001840856-26-000022.md) |
| Long-term debt | $m | [83.3](/filings/0001840856-23-000059.md) | [84.3](/filings/0001628280-25-011821.md) | [85.5](/filings/0001840856-24-000019.md) | [0.0](/filings/0001840856-24-000028.md) | [39.7](/filings/0001840856-24-000040.md) | [0.0](/filings/0001628280-25-011821.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001840856-23-000059.md) | [0.0](/filings/0001840856-24-000028.md) | [0.0](/filings/0001840856-24-000019.md) | [0.0](/filings/0001840856-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [25.9](/filings/0001840856-24-000040.md) | [28.2](/filings/0001840856-26-000006.md) | [155](/filings/0001628280-25-039596.md) | [224](/filings/0001840856-25-000022.md) | [296](/filings/0001840856-25-000022.md) | [183](/filings/0001840856-26-000022.md) | [397](/filings/0001840856-26-000022.md) | [360](/filings/0001840856-26-000022.md) | [399](/filings/0001840856-25-000022.md) | [464](/filings/0001840856-26-000022.md) | [461](/filings/0001840856-26-000022.md) | [490](/filings/0001840856-26-000022.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(20.2) d](/filings/0001840856-24-000040.md) | [(13.9) d](/filings/0001840856-26-000006.md) | [(21.9)](/filings/0001628280-25-024654.md) | [(18.5) d](/filings/0001628280-25-039596.md) | [(35.3) d](/filings/0001840856-25-000022.md) | [(33.1) d](/filings/0001840856-26-000006.md) | [(19.2)](/filings/0001840856-26-000015.md) | [(24.5) d](/filings/0001840856-26-000022.md) | [(32.7) d](/filings/0001840856-25-000022.md) | [(21.9) d](/filings/0001840856-26-000006.md) | [(26.3)](/filings/0001840856-26-000015.md) | [(33.7) d](/filings/0001840856-26-000022.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001840856-24-000040.md) | [0.1 d](/filings/0001840856-26-000006.md) | [0.1](/filings/0001628280-25-024654.md) | [0.2 d](/filings/0001628280-25-039596.md) | [0.2 d](/filings/0001840856-25-000022.md) | [0.1 d](/filings/0001840856-26-000006.md) | [0.2](/filings/0001840856-26-000015.md) | [0.2 d](/filings/0001840856-26-000022.md) | [0.2 d](/filings/0001840856-25-000022.md) | [0.4 d](/filings/0001840856-26-000006.md) | [0.5](/filings/0001840856-26-000015.md) | [0.4 d](/filings/0001840856-26-000022.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [197](/filings/0001840856-23-000059.md) | [205](/filings/0001840856-24-000019.md) | [221](/filings/0001840856-24-000028.md) | [242](/filings/0001840856-24-000040.md) | [287](/filings/0001628280-25-024654.md) | [332](/filings/0001628280-25-039596.md) | [360](/filings/0001840856-25-000022.md) | [414](/filings/0001840856-26-000015.md) | [402](/filings/0001840856-26-000022.md) | [412](/filings/0001840856-25-000022.md) | [430](/filings/0001840856-26-000015.md) | [439](/filings/0001840856-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,461,000 at 2022-03-09, from the cover of the [10-K filed 2022-03-09](/filings/0001213900-22-011342.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.